SaaS
Shaperon Email
AI
Shaperon Review AI Shaperon Monitoring AI Shaperon Safety AI Contact Us

Pharma-focused AI for
producing more content from existing materials

Content AI overview

Create materials aligned with production guidelines in short lead times and at lower cost*1 *2. Expand your content lineup and shorten your promotional cycle.

Content AI overview

Do you face these kinds of challenges
in content production for your marketing strategy?

Delays in delivering information

It takes months from planning to delivery, making it hard to share congress updates and the latest evidence in a timely way.

Loss of information freshness

Limits on production cost

External production costs are high, so budget constraints prevent broader content development and series expansion.

Limits on production cost

Growing operational burden

Drafting and compliance review require substantial effort, making it hard to stay focused on strategy.

Growing operational burden

Concerns about AI adoption

Teams hesitate to adopt AI because they worry about misinformation and whether outputs will align with internal rules.

Concerns about AI adoption
SOLUTION

Content AI solves challenges in cost,
speed, and compliance

Simply upload your existing materials, such as PDFs or videos, and the AI will automatically produce and deliver digital content such as videos and HTML*1.

Submit your existing material data as-is

PDF material Video material

Supported materials

Product presentation slides Leaflets Lecture videos Congress presentation materials Disease-awareness materials Recorded footage
AI conversion
Content AI
As fast as 5 business days*3
Video
Summary
HTML
SERVICES

Four content production menus

Choose the best content format based on the materials you already have.

01
Slide Movie

Create narrated videos
from slide decks

Simply upload your product presentation slides and the workflow runs end-to-end, from script generation to narration and video production.

Narrated AI video
What to prepare
PDF material
  • PDF material
  • Slide deck
AI conversion
Deliverable
Narrated AI video
  • Narrated AI video
02
HTML Contents

Convert PDFs directly into
HTML for web and email

Automatically generate mobile-friendly HTML from leaflet PDFs and meeting-slide PDFs, greatly reducing production work for multichannel deployment.

HTML for web publishingHTML for web / distributionHTML for email distributionMobile optimizationAEO support
What to prepare
PDF data
  • Leaflets
  • Slides, etc.
AI conversion
Deliverable
HTML content
  • HTML for web / email
03
Webinar Digest

Create multiple formats
from lecture data

Create content from event materials in formats such as summary reports, digest videos, and email templates.

Summary reportSummary emailDigest video
What to prepare
PDF data Lecture data
  • Lecture slides
  • Recorded footage, etc.
AI conversion
Deliverable
Summary report Digest video
  • Summary report
  • Digest video
04
Segmentation Coming Soon

AI generates multiple
versions optimized by physician segment

Using a single existing asset, AI creates slides, videos, and other content optimized for physician segments such as conservative or proactive prescribers, making personalized rollout more efficient.

PersonalizationOmnichannel support
What to prepare
PDF data
  • PDF material
  • Tone instructions (voice, depth, emphasis, etc.)
AI conversion
Deliverable
Conservative prescribers Conservative prescribers
Proactive prescribers Proactive prescribers
  • Segment-specific content
Sample
Sample

Your existing slides can reach this level
of quality in as little as 5 business days*3.

View Sample
RESULTS

How Content AI improves the
speed and quality of information delivery

Cost
vs. outsourcing
1/3*2

Lower cost expands the range of content you can produce

Compared with conventional outsourcing, content can be produced at lower cost. That opens up projects such as FAQ videos and disease-awareness content that may previously have been out of reach.

Speed
As fast as
5business days*3

More timely information delivery

Share time-sensitive information such as regulatory changes and new product updates quickly, and get it to physicians ahead of competitors.

Compliance
Aligned with
pharma advertising guidelines*4

Compliance alignment and support for company-specific rules

Draft content based on pharmaceutical advertising guidelines. Adjustments for company-specific rules*5 are also possible, reducing workload for both production and review.

USE CASES

Get the most from your existing assets.

Case 1Rapid updates on the latest evidence

Turn congress slides into videos and HTML right away, so content where freshness matters can reach physicians ahead of competitors.

Rapid updates on the latest evidence
Case 2Use summaries for post-event follow-up

Create summaries and digest videos immediately after events. MRs can quickly catch up on the lecture content and follow up with physicians promptly and effectively.

Use summaries for post-event follow-up
Case 3Expand your owned media content

Turn existing slides and materials, such as disease-awareness content, into videos. Narration and animation help make them easier to understand while expanding site content with less effort.

Expand your owned media content
FLOW

Flow to delivery

1

Contact Us

Please contact us first and tell us about your challenges and the kinds of content you want to create.

2

Align on the production approach

We review your source data, target physician audience, production goals, and desired options, then align on the content production approach.

3

Draft production and revision

We prepare the first draft based on the agreed production approach, reflect revision requests, and address feedback after review by your internal approval team.

4

Delivery

We deliver the final version.

FAQ

Frequently asked questions

The service is designed to produce content aligned with production guidelines. It can also output content that reflects review criteria tailored to each company, and additional development support is available when needed.
Yes. We provide a review process that combines AI and human review. If revisions are needed after your internal review following delivery, we also support changes as much as possible.
In principle, rights belong to the pharmaceutical company after delivery. Detailed rights depend on the specific contract terms.
Minor revisions such as wording changes can be handled at no additional cost. Major structural changes may require additional fees.

Not limited to the services shown on this page,
you can consult us about any content-production challenge.

Contact Us